EPO Threats Leveling off? Amgen Beats Q2 Estimates
By Jennifer Boggs
Monday, August 1, 2011
Like its fellow big biotechs, Amgen Inc. posted solid numbers for the second quarter. The Thousand Oaks, Calif.-based firm reported net income of $1.28 billion and earnings per share (EPS) of $1.37, well ahead of consensus estimates of $1.28 per share.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.